ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., the innovator in anatomy conserving surgery technologies, today announced that it has entered into an agreement with BioDlogics to distribute that company’s line of allograft tissue forms. “BioDlogics’ products provide a very attractive complement to our current product line,” said John Booth, CEO for Spineology. “We believe that recent advances in regenerative medicine have the potential to significantly improve patient outcomes in numerous clinical applications. We look forward to working with BioDlogics to offer its line of novel allograft tissue to surgeons using our products.”
